相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models
Elizabeth Iorns et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer
Na Li et al.
MOLECULAR BIOLOGY REPORTS (2012)
Denosumab in patients with cancer-a surgical strike against the osteoclast
Janet E. Brown et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
David A. Reardon et al.
FUTURE ONCOLOGY (2011)
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study
Tobias Baeuerle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Targeting of αv-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer
Geertje van der Horst et al.
NEOPLASIA (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Therapeutic targets for bone metastases in breast cancer
Philippe Clezardin
BREAST CANCER RESEARCH (2011)
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
Carlos Mas-Moruno et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Drug-Induced Vessel Remodeling in Bone Metastases as Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging and Vessel Size Imaging: A Longitudinal In vivo Study
Tobias Baeuerle et al.
CLINICAL CANCER RESEARCH (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Integrins in Bone Metastasis Formation and Potential Therapeutic Implications
P. Clezardin
CURRENT CANCER DRUG TARGETS (2009)
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
Ludwig G. Strauss et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R. Reynolds et al.
NATURE MEDICINE (2009)
The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
Gian Carlo Alghisi et al.
PLOS ONE (2009)
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors
Ludwig G. Strauss et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma
Uwe Haberkorn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Tumor ανβ3 integrin is a therapeutic target for breast cancer bone metastases
Yingshe Zhao et al.
CANCER RESEARCH (2007)
Inhibition of integrin αvP3 reduces blood-brain barrier breakdown in focal ischernia in rats.
Norihito Shimamura et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design
Kathleen W. Beekman et al.
CLINICAL GENITOURINARY CANCER (2006)
Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein
T Bäuerle et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
VEGF-integrin interplay controls tumor growth and vascularization
S De et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inhibition of alpha v beta 3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases
JA Nemeth et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Expression of hexokinase II and Glut-1 in untreated human breast cancer
RS Brown et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro
MWB Pedersen et al.
NEOPLASIA (2001)
分享论文
